Drug Interactions and Side Effects of Humulin N and Humalog and Humulin R and Lactulose and Synthroid and Estradiol Inj and Diovan and Vitamin B-12 and Lantus and Novolog and Xanax and Pravachol and Lasix and Plendil and Atacand
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 183070 | Jul, 26, 2006 | 89 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Humulin N | insulin recombinant human |
Humalog | insulin lispro recombinant |
Humulin R | insulin recombinant human |
Lactulose | lactulose |
Synthroid | levothyroxine sodium |
Estradiol Inj | estradiol |
Diovan | valsartan |
Vitamin B-12 | ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e |
Lantus | insulin glargine recombinant |
Novolog | insulin aspart recombinant |
Xanax | alprazolam |
Pravachol | pravastatin sodium |
Lasix | furosemide |
Plendil | felodipine |
Atacand | candesartan cilexetil |
| Name |
Abdominal Distension |
Acoustic Neuroma |
Autonomic Neuropathy |
Blepharitis |
Blindness Unilateral |
Blood Cholesterol Increased |
Blood Glucose Decreased |
Blood Glucose Increased |
Cystitis |
Diabetic Retinopathy |
Drug Ineffective |
Dyspepsia |
Dysphonia |
Fungal Infection |
Hyperhidrosis |
Hypersensitivity |
Hypertension |
Impaired Gastric Emptying |
Incontinence |
Injection Site Calcification |
Insomnia |
Macular Degeneration |
Malabsorption |
Musculoskeletal Pain |
Pruritus |
Pseudophakia |
Rash Pruritic |
Scotoma |
Sepsis |
Weight Decreased |
Results from eHealthMe : 55 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Abdominal Distension | 51 (92.73%) |
Acoustic Neuroma | 55 (100.00%) |
Autonomic Neuropathy | 55 (100.00%) |
Blepharitis | 55 (100.00%) |
Blindness Unilateral | 43 (78.18%) |
Blood Cholesterol Increased | 55 (100.00%) |
Blood Glucose Decreased | 55 (100.00%) |
Blood Glucose Increased | 55 (100.00%) |
Cystitis | 55 (100.00%) |
Diabetic Retinopathy | 27 (49.09%) |
Drug Ineffective | 47 (85.45%) |
Dyspepsia | 55 (100.00%) |
Dysphonia | 51 (92.73%) |
Fungal Infection | 55 (100.00%) |
Hyperhidrosis | 55 (100.00%) |
Hypersensitivity | 39 (70.91%) |
Hypertension | 55 (100.00%) |
Impaired Gastric Emptying | 55 (100.00%) |
Incontinence | 55 (100.00%) |
Injection Site Calcification | 55 (100.00%) |
Insomnia | 55 (100.00%) |
Macular Degeneration | 55 (100.00%) |
Malabsorption | 51 (92.73%) |
Musculoskeletal Pain | 39 (70.91%) |
Pruritus | 55 (100.00%) |
Pseudophakia | 55 (100.00%) |
Rash Pruritic | 55 (100.00%) |
Scotoma | 47 (85.45%) |
Sepsis | 55 (100.00%) |
Weight Decreased | 55 (100.00%) |
Top 3 (total: 2. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Multi-vitamin | 4 (0.42%) |
Vitamin B12 | 4 (0.42%) |
Death reported: 0
| Name | Count (% of total reports) |
Incontinence | 55 (100.00%) |
Injection Site Calcification | 55 (100.00%) |
Impaired Gastric Emptying | 55 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
